Financials in USD. Standardized financial statements.
A compact view of how Titan Medical Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $17.96M | $0 | $19.92M | $21.06M | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | -100.0% | -5.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $189,411 | $825,924 | $0 | $0 | $33,311 | $27,559 | $17,984 | $24,343 |
| Gross Profit? | $17.77M | -$825,924 | $19.92M | $21.06M | -$33,311 | -$27,559 | -$17,984 | -$24,343 |
| Gross Margin? | +98.9% | 0.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $7.45M | $42.17M | $49.94M | $16.39M | $60.61M | $37.64M | $19.55M | $27.17M |
| Operating Income? | $10.31M | -$43.00M | -$30.71M | $4.42M | -$60.64M | -$37.67M | -$19.56M | -$27.20M |
| EBITDA? | $7.52M | -$39.94M | -$13.86M | -$22.84M | -$42.42M | -$21.46M | -$34.78M | -$23.02M |
| Income Before Tax | $7.10M | -$40.91M | -$14.67M | -$25.46M | -$42.88M | -$21.48M | -$34.79M | -$23.04M |
| Income Tax Expense | $24,440 | -$53,781 | $55,507 | $0 | $0 | $0 | -$2 | $3 |
| Net Income? | $6.95M | -$40.86M | -$14.73M | -$25.46M | -$42.88M | -$21.48M | -$34.79M | -$23.04M |
| EPS? | $0.06 | $-0.37 | $-0.14 | $-0.38 | $-1.40 | $-1.29 | $-4.40 | $-4.72 |
| Diluted EPS? | $0.06 | $-0.37 | $-0.14 | $-0.38 | $-1.40 | $-1.29 | $-4.40 | $-4.72 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality